Pharmacodynamics<unk>  has antiandrogenic activity, progestogenic activity, weak partial glucocorticoid activity, weak steroidogenesis inhibitor activity, and agonist activity at the pregnane X receptor. It has no estrogenic or antimineralocorticoid activity. In terms of potency,<unk>  is described as a highly potent progestogen, a moderately potent antiandrogen, and a weak glucocorticoid. Due to its progestogenic activity,<unk>  has antigonadotropic effects, and is able to suppress fertility and sex-hormone levels in both males and females. Pharmacokinetics<unk> <unk> n be taken by mouth or by injection into muscle. It has near-complete oral bioavailability, is highly and exclusively bound to albumin in terms of plasma protein binding, is metabolized in the liver by hydroxylation and conjugation, has 15β-hydroxycyproterone<unk>  (15β-OH-CPA) as a single major active metabolite, has a long elimination half-life of about 2 to 4 days regardless of route of administration, and is excreted in feces primarily and to a lesser extent in urine.
Cyproterone acetate
Desoxymethyltestosterone
15β-Hydroxycyproterone acetate
Oxandrolone
Acetothiolutamide
Goserelin
Darolutamide
Bisoctrizole